Skip to main navigation
  • Overview
  • Press Releases
  • Events & Presentations
    • Upcoming Events
    • Past Events
    • Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Swiss Statutory Financials
    • PFIC Annual Information Statement
  • Stock Information
    • Stock Quote & Chart
    • Historical Price
    • Investment Calculator
  • Shareholder Services
    • Investor FAQs
    • Document Request
    • Contact IR
  • Back to CRISPR »

Press Releases

Press Releases

Keyword Search

May 28, 2026

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

May 06, 2026

CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference

May 04, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Apr 07, 2026

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 11, 2026

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

Mar 10, 2026

CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering

Feb 12, 2026

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Jan 12, 2026

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Jan 05, 2026

CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference


Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Interested in joining our team? Careers at CRISPR

© 2026 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions